miRNome and Proteome Profiling of Small Extracellular Vesicles Secreted by Human Glioblastoma Cell Lines and Primary Cancer Stem Cells
- PMID: 36009432
- PMCID: PMC9405730
- DOI: 10.3390/biomedicines10081886
miRNome and Proteome Profiling of Small Extracellular Vesicles Secreted by Human Glioblastoma Cell Lines and Primary Cancer Stem Cells
Abstract
Glioblastoma (GBM) is the most common and aggressive brain tumor in adults. Despite available therapeutic interventions, it is very difficult to treat, and a cure is not yet available. The intra-tumoral GBM heterogeneity is a crucial factor contributing to poor clinical outcomes. GBM derives from a small heterogeneous population of cancer stem cells (CSCs). In cancer tissue, CSCs are concentrated within the so-called niches, where they progress from a slowly proliferating phase. CSCs, as most tumor cells, release extracellular vesicles (EVs) into the surrounding microenvironment. To explore the role of EVs in CSCs and GBM tumor cells, we investigated the miRNA and protein content of the small EVs (sEVs) secreted by two GBM-established cell lines and by GBM primary CSCs using omics analysis. Our data indicate that GBM-sEVs are selectively enriched for miRNAs that are known to display tumor suppressor activity, while their protein cargo is enriched for oncoproteins and tumor-associated proteins. Conversely, among the most up-regulated miRNAs in CSC-sEVs, we also found pro-tumor miRNAs and proteins related to stemness, cell proliferation, and apoptosis. Collectively, our findings support the hypothesis that sEVs selectively incorporate different miRNAs and proteins belonging both to fundamental processes (e.g., cell proliferation, cell death, stemness) as well as to more specialized ones (e.g., EMT, membrane docking, cell junction organization, ncRNA processing).
Keywords: cancer stem cells; extracellular vesicles; glioblastoma; miRNAs; proteome.
Conflict of interest statement
The authors declare no conflict of interest.
Figures









Similar articles
-
Coculture with Neural Stem Cells May Shift the Transcription Profile of Glioblastoma Multiforme towards Cancer-Specific Stemness.Int J Mol Sci. 2023 Feb 7;24(4):3242. doi: 10.3390/ijms24043242. Int J Mol Sci. 2023. PMID: 36834653 Free PMC article.
-
Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles.Int J Mol Sci. 2020 Nov 11;21(22):8491. doi: 10.3390/ijms21228491. Int J Mol Sci. 2020. PMID: 33187334 Free PMC article.
-
Self-Functionalized Superlattice Nanosensor Enables Glioblastoma Diagnosis Using Liquid Biopsy.ACS Nano. 2023 Oct 24;17(20):19832-19852. doi: 10.1021/acsnano.3c04118. Epub 2023 Oct 12. ACS Nano. 2023. PMID: 37824714
-
Role of Tumor-Derived Extracellular Vesicles in Glioblastoma.Cells. 2021 Feb 28;10(3):512. doi: 10.3390/cells10030512. Cells. 2021. PMID: 33670924 Free PMC article. Review.
-
Extracellular vesicles in the biology of brain tumour stem cells--Implications for inter-cellular communication, therapy and biomarker development.Semin Cell Dev Biol. 2015 Apr;40:17-26. doi: 10.1016/j.semcdb.2015.02.011. Epub 2015 Feb 23. Semin Cell Dev Biol. 2015. PMID: 25721810 Review.
Cited by
-
Understanding Aβ25-35 peptide altered exosomal proteome and associated pathways linked with the Alzheimer's disease pathogenesis using human neuroblastoma SH-SY5Y Cells.Metab Brain Dis. 2024 Nov 20;40(1):25. doi: 10.1007/s11011-024-01469-7. Metab Brain Dis. 2024. PMID: 39565424
-
Proteomics Studies on Extracellular Vesicles Derived from Glioblastoma: Where Do We Stand?Int J Mol Sci. 2024 Sep 10;25(18):9778. doi: 10.3390/ijms25189778. Int J Mol Sci. 2024. PMID: 39337267 Free PMC article. Review.
-
Extracellular vesicle heterogeneity through the lens of multiomics.Cell Rep Med. 2025 Jul 15;6(7):102161. doi: 10.1016/j.xcrm.2025.102161. Epub 2025 Jun 6. Cell Rep Med. 2025. PMID: 40482644 Free PMC article.
-
Nanotherapeutic strategies exploiting biological traits of cancer stem cells.Bioact Mater. 2025 Apr 3;50:61-94. doi: 10.1016/j.bioactmat.2025.03.016. eCollection 2025 Aug. Bioact Mater. 2025. PMID: 40242505 Free PMC article. Review.
References
-
- Cenciarelli C., Marei H.E., Zonfrillo M., Casalbore P., Felsani A., Giannetti S., Trevisi G., Althani A., Mangiola A. The interference of Notch1 target Hes1 affects cell growth, differentiation, and invasiveness of Glioblastoma stem cells through modulation of oncogenic signals. Oncotarget. 2017;8:17873–17886. doi: 10.18632/oncotarget.15013. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases